DYRK2 and lung carcinoma: Multiple publications carrying out sequencing or immunohistochemistry to study mRNA/protein levels of DYRK2 have suggested that DYRK2 is a tumor suppressor in colorectal (60, 61, 62, 63), liver (64), brain (65), and lung cancers (66, 67) and that the kinase promotes chemosensitivity in ovarian cancer (68).